$0.56
+0.01
(+2.69%)▲
5.0%
Downside
Day's Volatility :13.34%
Upside
8.78%
7.14%
Downside
52 Weeks Volatility :82.01%
Upside
80.62%
Period | Logicmark Inc | Index (Russel 2000) |
---|---|---|
3 Months | -32.7% | 0.0% |
6 Months | -47.47% | 0.0% |
1 Year | -80.76% | 0.0% |
3 Years | -98.81% | -20.2% |
Market Capitalization | 1.2M |
Book Value | $5.28 |
Earnings Per Share (EPS) | -10.59 |
Wall Street Target Price | 3.5 |
Profit Margin | -148.62% |
Operating Margin TTM | -69.16% |
Return On Assets TTM | -21.51% |
Return On Equity TTM | -73.71% |
Revenue TTM | 9.7M |
Revenue Per Share TTM | 5.93 |
Quarterly Revenue Growth YOY | -7.1% |
Gross Profit TTM | 7.2M |
EBITDA | -6.6M |
Diluted Eps TTM | -10.59 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -3.85 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | -0.88 |
EPS Estimate Next Quarter | -1.07 |
What analysts predicted
Upside of 525.0%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 17.1M | ↓ 26.59% |
Net Income | -7.1M | ↓ 14.22% |
Net Profit Margin | -41.42% | ↓ 5.97% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 17.1M | ↑ 0.12% |
Net Income | -2.4M | ↓ 66.59% |
Net Profit Margin | -13.82% | ↑ 27.6% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 11.4M | ↓ 33.23% |
Net Income | -2.9M | ↑ 20.97% |
Net Profit Margin | -25.04% | ↓ 11.22% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 10.0M | ↓ 12.42% |
Net Income | -11.7M | ↑ 308.65% |
Net Profit Margin | -116.82% | ↓ 91.78% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 11.9M | ↑ 18.9% |
Net Income | -6.9M | ↓ 40.85% |
Net Profit Margin | -58.11% | ↑ 58.71% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 9.9M | ↓ 16.67% |
Net Income | -14.6M | ↑ 110.12% |
Net Profit Margin | -146.54% | ↓ 88.43% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.1M | ↓ 21.99% |
Net Income | -2.4M | ↑ 18.89% |
Net Profit Margin | -113.49% | ↓ 39.03% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.8M | ↑ 30.9% |
Net Income | -1.9M | ↓ 21.66% |
Net Profit Margin | -67.92% | ↑ 45.57% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.3M | ↓ 17.18% |
Net Income | -2.3M | ↑ 18.83% |
Net Profit Margin | -97.46% | ↓ 29.54% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.4M | ↑ 1.73% |
Net Income | -1.4M | ↓ 36.31% |
Net Profit Margin | -61.02% | ↑ 36.44% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.4M | ↑ 2.47% |
Net Income | -9.0M | ↑ 523.4% |
Net Profit Margin | -371.23% | ↓ 310.21% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 2.4M | ↑ 0.0% |
Net Income | -9.0M | ↑ 0.0% |
Net Profit Margin | -371.23% | ↑ 0.0% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 38.1M | ↓ 21.12% |
Total Liabilities | 21.5M | ↓ 21.22% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 25.0M | ↓ 34.18% |
Total Liabilities | 16.5M | ↓ 23.17% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 26.9M | ↑ 7.59% |
Total Liabilities | 16.0M | ↓ 3.29% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 30.1M | ↑ 11.78% |
Total Liabilities | 1.7M | ↓ 89.19% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 25.6M | ↓ 14.88% |
Total Liabilities | 25.6M | ↑ 1384.8% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 17.0M | ↓ 33.63% |
Total Liabilities | 2.1M | ↓ 91.79% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 25.6M | ↓ 6.96% |
Total Liabilities | 25.6M | ↑ 845.51% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 27.5M | ↑ 7.09% |
Total Liabilities | 1.7M | ↓ 93.39% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 25.6M | ↓ 6.63% |
Total Liabilities | 1.7M | ↑ 0.35% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 25.2M | ↓ 1.9% |
Total Liabilities | 2.3M | ↑ 36.15% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 17.0M | ↓ 32.34% |
Total Liabilities | 2.1M | ↓ 9.17% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 17.0M | ↑ 0.0% |
Total Liabilities | 2.1M | ↑ 0.0% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -50.2K | ↓ 99.11% |
Investing Cash Flow | -3.2M | ↑ 94.44% |
Financing Cash Flow | 3.1M | ↓ 62.12% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.2M | ↓ 4563.37% |
Investing Cash Flow | 2.7M | ↓ 185.79% |
Financing Cash Flow | -2.0M | ↓ 165.33% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.7M | ↑ 16.57% |
Investing Cash Flow | -395.8K | ↑ 39.64% |
Financing Cash Flow | -75.0K | ↑ 0.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.4M | ↓ 18.59% |
Investing Cash Flow | -395.8K | ↑ 0.0% |
Financing Cash Flow | 4.3M | ↓ 5874.91% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -1.8M | ↑ 31.1% |
Investing Cash Flow | -395.8K | ↑ 0.0% |
Financing Cash Flow | 76.7K | ↓ 98.23% |
Sell
Neutral
Buy
Logicmark Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Logicmark Inc | -13.74% | -47.47% | -80.76% | -98.81% | -98.81% |
![]() Solventum Corp | 13.4% | -16.71% | -16.71% | -16.71% | -16.71% |
![]() Veeva Systems Inc. | 1.24% | -10.63% | -7.18% | -43.19% | 9.43% |
![]() Ge Healthcare Technologies Inc. | 2.46% | 9.25% | 3.22% | 32.12% | 32.12% |
![]() Healthequity Inc | -3.68% | 3.76% | 26.99% | 6.89% | -2.18% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Logicmark Inc | NA | NA | NA | -3.85 | -0.74 | -0.22 | NA | 5.28 |
![]() Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
![]() Veeva Systems Inc. | 54.35 | 54.35 | 1.35 | 4.76 | 0.13 | 0.06 | NA | 30.25 |
![]() Ge Healthcare Technologies Inc. | 23.5 | 23.5 | 20.11 | 4.27 | 0.22 | 0.06 | 0.0 | 16.23 |
![]() Healthequity Inc | 85.91 | 85.91 | 2.29 | 2.19 | 0.04 | 0.03 | NA | 24.11 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Logicmark Inc | Sell | $1.2M | -98.81% | NA | -148.62% |
![]() Solventum Corp | Hold | $10.8B | -16.71% | NA | 15.73% |
![]() Veeva Systems Inc. | Buy | $29.8B | 9.43% | 54.35 | 22.34% |
![]() Ge Healthcare Technologies Inc. | Buy | $36.9B | 32.12% | 23.5 | 8.05% |
![]() Healthequity Inc | Buy | $6.9B | -2.18% | 85.91 | 7.71% |
Insights on Logicmark Inc
Revenue is up for the last 4 quarters, 2.32M → 2.42M (in $), with an average increase of 1.4% per quarter
Netprofit is down for the last 3 quarters, -1.44M → -9.00M (in $), with an average decrease of 261.7% per quarter
In the last 1 year, Healthequity Inc has given 27.0% return, outperforming this stock by 107.8%
Vanguard Group Inc
Tower Research Capital LLC
UBS Group AG
Group One Trading, LP
Advisor Group Holdings, Inc.
nxt-id, inc. (nasdaq: nxtd) about nxt- id inc. - mobile security for a mobile world: (nxtd) (nxtdw): nxt-id, inc.'s innovative mobilebio® solution mitigates consumer risks associated with mobile computing, m-commerce and smart os-enabled devices. the company is focused on the growing m-commerce market, launching its innovative mobilebio® suite of biometric solutions that secure consumers' mobile platforms led by wocket®; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. wocket was recognized as one of the top technology products at ces 2015 by multiple media outlets including wired.com. the wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.wocketwallet.com/ nxt-id’ wholly owned subsidiary, 3d-id llc, is engaged in biometric identification and has 22 licensed patents in the field of 3d facial recognition http://www.nxt-id.com/, http://3d-id.net/ order your wocket
Organization | Logicmark Inc |
Employees | 26 |
CEO | Ms. Chia-Lin Simmons |
Industry | Miscellaneous |
A Spac I Acquisition Corp
$0.56
+2.69%
Keyarch Acquisition Corp
$0.56
+2.69%
Connexa Sports Technologies Inc
$0.56
+2.69%
Us Value Etf
$0.56
+2.69%
First Wave Biopharma Inc
$0.56
+2.69%
Global X Msci Next Emerging
$0.56
+2.69%
Fat Projects Acquisition Corp
$0.56
+2.69%
Capital Link Global Fintech
$0.56
+2.69%
Applied Uv Inc
$0.56
+2.69%